Business
Latest Headlines
Top Stories
Breaking News
Earnings
Biotech
Investors
Stock Alerts
IPOs
M&A
Canadian
UK
Wallstreet Events
- Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
- Drug Approvals
- Clinical Trial Calendar

Economic News
US
Europe
Asia
Global
Economic Calendar
Economic Scorecard

Crypto
Cryptocurrency
Blockchain

Markets
Morning Mkt Analysis
US Commentary
European Commentary
Asian Commentary
Canadian Commentary
Indian Commentary
Commodities
Bonds
Currencies

Politics
US
World
White House
Elections
General News

Forex
FX Top Stories
Currency Analysis
Currency Alerts
Economic Calendar
Economic Scorecard

Health
Coronavirus
COVID-19 Calendar
Diet & Fitness
Cannabis
Kids Health
Men's Health
Women's Health
Cancer News
Drug Development
Mental Health

Slide Shows

Entertainment
Top Stories
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

Content Licensing
Newswires & Feeds
Content Syndication
Digital Signage Services
Radio News Services

Premium
Intelligent Investor
Biotech Investor NEW
Login

Latest News Videos
Free Content
RSS Feeds
Press Releases
Search
Contact Us

Business
Corp. News
- Latest Headlines
- Biotech
- Investors
- Stock Alerts
- IPOs
- M&A
Industry News
- Technology
- Software
- Banking
- Automotive
- Energy
- More
Corp. Calendars
Earnings Calendar
FDA Calendars
- Drug Approvals
- Clinical Trial Calendar
Ratings Changes
Economy
- US
- Europe
- Asia
- Global
- Economic Calendar
- Economic Scorecard
Crypto
- Cryptocurrency
- Blockchain
Markets
Market News
Politics
- US
- World
- White House
- Elections
- General News
Forex
Health
Health News
Slide Shows
Entertainment
Entertainment News
- Top Stories
Music News
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre
Content Licensing
Premium
More

Novo Nordisk B A/S (NVO)

Novo Nordisk Invests €432 Mln In Ireland Facility To Expand GLP-1 Manufacturing Capacity 3/2/2026 7:23:18 AM

Weekly Buzz: MGNX's LINNET Trial On Hold; ETON, ALUR Get FDA Nod; GILD Snaps Up ACLX 2/27/2026 9:17:16 AM

Novo Nordisk, Vivtex Partner To Develop Next-generation Oral Medicines For Obesity And Diabetes 2/25/2026 9:59:35 AM

Novo Nordisk Partners Vivtex To Develop Next-generation Oral Medicines For Obesity And Diabetes 2/25/2026 8:26:12 AM

Novo Nordisk, Vivtex Partner To Advance Oral Biologics For Obesity, Diabetes, And Related Conditions 2/25/2026 8:15:00 AM

Novo Nordisk, United Laboratories International Announce Positive Topline Data From UBT251 Trial 2/24/2026 11:57:29 AM

Novo Nordisk Reports Positive Phase 2 Results For UBT251 Triple Agonist In Obesity 2/24/2026 10:12:50 AM

Novo Nordisk To Cut US List Price For Wegovy, Ozempic And Rybelsus By Up To 50% 2/24/2026 8:52:07 AM

Novo Nordisk To Slash US List Price For Wegovy, Ozempic, And Rybelsus, Effective Jan 1, 2027 2/24/2026 8:18:55 AM

Novo Nordisk And United Lab Reports Positive Results From Chinese Phase 2 Trial Of UBT251 In Obesity 2/24/2026 4:59:52 AM

Novo Nordisk Shares Slide 15% After CagriSema Misses Key Trial Endpoint 2/23/2026 9:55:23 AM

Novo Nordisk Shares Fall After CagriSema Misses Key Goal In Head-to-Head Trial Against Zepbound 2/23/2026 7:33:53 AM

Novo Nordisk : EC Approves 7.2 Mg Maintenance Dose Of Injectable Wegovy For Adults With Obesity 2/17/2026 10:02:17 AM

FDA Flags Novo Nordisk Wegovy Pill Ad Over Misleading Claims 2/9/2026 6:09:02 PM

Novo Nordisk Files Lawsuit Against Hims & Hers 2/9/2026 9:36:04 AM

Novo Nordisk Asks Court To Permanently Ban Hims & Hers From Selling Unapproved, Compounded Drugs 2/9/2026 9:31:22 AM

Novo Nordisk Sues Hims & Hers To Protect Patients From Potentially Unsafe Copycat Semaglutide Drugs 2/9/2026 9:28:44 AM

Novo Nordisk Targets Up To DKK 15 Bln In B-share Buybacks Over Next 12 Months 2/9/2026 7:34:11 AM

Novo Nordisk To Repurchase B Shares For DKK 3.8 Bln From February 2026 To 4 May 2026 2/9/2026 7:31:52 AM

FDA Crackdown Forces Hims & Hers To Abandon Plans To Sell Compounded Semaglutide Weight-Loss Pills 2/8/2026 12:04:14 AM

Older Articles

Copyright © 2026 RTTNews. All rights reserved. By using this site, you agree to the Terms of Service. About Us | Contact Us | Privacy | Sitemap